ConductScience.org, home

Gene · 56914

OTOR: otoraplin

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. OTOR: otoraplin. Genes, record 56914. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/56914

On this page

Gene

Symbol
OTOR
HGNC
Name
otoraplin
HGNC
NCBI Gene ID
56914
NCBI Gene
HGNC ID
HGNC:8517
HGNC
Ensembl
ENSG00000125879
NCBI Gene
Aliases
FDP, MIAL, MIAL1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9NRC9Otoraplin1280Ensembl, GeneID, HGNC

Source UniProt

Patents104

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1456690Q9NRC9Espacenet
EP 4650780 A22025-11-191182Q9NRC9Espacenet
JP 2025147176 A2025-10-069880Q9NRC9Espacenet
JP 2025529142 A2025-09-047246Q9NRC9Espacenet
US 12371689 B22025-07-297246Q9NRC9Espacenet
JP 2025517970 A2025-06-121182Q9NRC9Espacenet
JP 2025028160 A2025-02-289880Q9NRC9Espacenet
KR 1020250010750 A2025-01-219880Q9NRC9Espacenet
JP 2024109657 A2024-08-149887Q9NRC9Espacenet
US 11446398 B22022-09-2060478Q9NRC9Espacenet

1 to 10 of 104

See all 104 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants203

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleOTOR papersNewest fiscal year
P30CA046592University of Michigan Rogel Cancer Center Support Grant 2023-202822025
T32ES007015Molecular & Environmental Toxicology Predoctoral Training Program22025
P30CA014520UW Comprehensive Cancer Center Support12025
P30CA014599Cancer Center Support Grant12025
P30CA016672Cancer Center Support Grant12025
P30CA030199Cancer Center Support Grant (CCSG)12025
P30CA033572Cancer Center Support Grant12025
P30CA036727Buffett Cancer Center Support Grant12025
P30CA045508CSHL Cancer Center Support Grant12025
P30CA046934University of Colorado Cancer Center Support Grant12025

1 to 10 of 203Source NIH's project files

See all 203 nih grants

Papers1,445

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome.Front Med (Lausanne)202642755913PubTator, text miningPubMed
Fibrin Degradation Products Regulate Endothelial Barrier Function in Traumatic Brain Injury via the Actin Cytoskeleton.Neurotrauma Rep202642666666PubTator, text miningPubMed
Fibrin degradation products enhance plasmin activity and contribute to fibrinolysis during simulated trauma-induced coagulopathy.Blood Coagul Fibrinolysis202642083375PubTator, text miningPubMed
Analyzing Misinformation and Disinformation: Understanding Swiss COVID-19 Narratives Through Natural Language Processing Analysis.JMIR Infodemiology202641911325PubTator, text miningPubMed
Flexor Tendon Repair Using a New Looped Six- and Eight-Strand Technique-A Biomechanical Analysis.J Pers Med202641893012PubTator, text miningPubMed
Fibrinogen-Bmal1 signaling as a therapeutic target to limit aortic dissection by preserving VSMC contractility.Signal Transduct Target Ther202641856973PubTator, text miningPubMed
Analysis of clinical features of AECOPD at different altitudes and GOLD stages in high-altitude regions.BMJ Open Respir Res202641825891PubTator, text miningPubMed
Establishment of Age-Specific Reference Intervals for 16 Coagulation Parameters in Chinese Children Using Sysmex CN-6000 Analyzer: A Cross-Sectional Study.Health Sci Rep202641822764PubTator, text miningPubMed
Preparation of Felodipine-PEG Solid Dispersions by Solvent-Free scCO2 Processing and Their Translation into Orally Disintegrating Tablets.ACS Omega202641768666PubTator, text miningPubMed
Successful Management of Suspected Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in BRAF-Mutant Cholangiocarcinoma Following Treatment With Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors: A Case Report.
Cancer Rep (Hoboken)202641761754PubTator, text miningPubMed

1 to 10 of 1,445

See all 1,445 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/56914

GET https://conductscience.org/api/genes/v1/56914/patents?page=2